Chronic hypoparathyroidism and treatment with teriparatide.

Gemma MarcucciLaura MasiLuisella CianferottiFrancesca GiustiCaterina FossiSimone ParriGiorgio GronchiMaria Luisa Brandi

Published in: Endocrine (2021)

Since intervention trials evaluating the efficacy and safety of teriparatide in hypoparathyroid patients are not yet available, the routine use of this molecule poses some doubts.

Keyphrases

end stage renal disease
ejection fraction
randomized controlled trial
newly diagnosed
chronic kidney disease
bone mineral density
peritoneal dialysis
clinical practice
combination therapy
patient reported